Updated: Jul 01, 2021 20:51 IST
94% of patients with cancer respond well to COVID-19 vaccines: Study
Washington [US], July 1 (ANI): According to a new study, nearly all patients with cancer developed a good immune response to the COVID-19 mRNA vaccines three to four weeks after receiving their second dose.
Read more
हिंदी खबर